Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Capital International Investors TFII TFI International Inc. 13G/A 5.1% 2y
Robert Anthony Wilson SGRP SPAR Group, Inc. 13D 20.2% 2y
Scilex Holding Company SMNR Semnur Pharmaceuticals, Inc. 13D 39.9% 2y
Invesco Ltd. YUMC Yum China Holdings, Inc. 13G/A 2.2% 2y
Beryl Capital Management LLC SEG Seaport Entertainment Group Inc. 13G 6.9% 2y
Capital Research Global Investors TIXT TELUS International (Cda) Inc. Subordinate Voting Shares 13G/A 7.7% 2y
MORGAN STANLEY OM Outset Medical, Inc. 13G/A 1.4% 2y
Capital World Investors TNDM Tandem Diabetes Care Inc 13G/A 5% 2y
WELLINGTON MANAGEMENT GROUP LLP AKRO Akero Therapeutics, Inc. Common Stock 13G/A 10.12% 2y
Invesco Ltd. SMLP Summit Midstream Partners, LP 13G/A 0% 2y
Capital World Investors RVNC Revance Therapeutics, Inc. 13G/A 6.6% 2y
Karpus Management, Inc. NAD Nuveen Quality Municipal Income Fund 13G/A 4.8% 2y
EMBRAER S.A. EVEX Eve Holding, Inc. 13D/A 88.5% 2y
Embraer Aircraft Holding, Inc. EVEX Eve Holding, Inc. 13D/A 88.5% 2y
TRIAN FUND MANAGEMENT, L.P. WEN Wendy's Co 13D/A 15.19% 2y
Ying Luo GYRE Gyre Therapeutics, Inc. 13D 8.54% 2y
Songjiang Ma GYRE Gyre Therapeutics, Inc. 13D 7.62% 2y
Saba Capital Management, L.P. NPFD Nuveen Variable Rate Preferred & Income Fund 13D/A 4.89% 2y
Huatai Securities Co., Ltd. AMK AssetMark Financial Holdings, Inc. 13D/A 0% 2y
MAK CAPITAL ONE LLC SKY Champion Homes, Inc. 13D/A 4.8% 2y
Zall Development Investment Company Limited LITB LightInTheBox Holding Co., Ltd. 13D/A 25.4% 2y
Michael A. Davis (“Davis”) CYAN Cyanotech Corp 13D/A 22.8% 2y
Focused Compounding Fund, LP PRKA Parks America, Inc 13D/A 40.22% 2y
Wax Asset Management, LLC ASYS Amtech Systems Inc 13G/A 11.3% 2y
BAILLIE GIFFORD & CO STAA Staar Surgical Co 13G/A 3.18% 2y
Goodwood Inc. CSCIF COSCIENS Biopharma Inc. 13D 7.2% 2y
Mitchell P. Kopin RR Richtech Robotics Inc. 13G 4.99% 2y
Fairmount Funds Management LLC ORKA Oruka Therapeutics, Inc. 13D 19.99% 2y
Ramnarain Joseph Jaigobind SCPX Scorpius Holdings, Inc. 13G 9.13% 2y
Guy Levy BCAB BioAtla, Inc. 13D/A 5.5% 2y
Archon Capital Management LLC ARAY Accuray Inc 13G/A 0.8% 2y
BROWN CAPITAL MANAGEMENT LLC ENFN Enfusion, Inc. 13G/A 8.45% 2y
David B. Blundin EVER EverQuote, Inc. 13D/A 22.4% 2y
HELU CARLOS SLIM PBF PBF Energy Inc. 13G/A 17.6% 2y
Point72 Asset Management, L.P. TDOC Teladoc Health, Inc. 13G 5.1% 2y
APMH Invest A/S NE Noble Corp plc 13D/A 17.35% 2y
HELU CARLOS SLIM TALO Talos Energy Inc. 13D/A 23.8% 2y
Galkin Vladimir JBLU Jetblue Airways Corp 13D 10% 2y
Riot Platforms, Inc. KEEL Keel Infrastructure Corp. 13D/A 19.9% 2y
Core 4 Capital Corp. BNKK Bonk, Inc. 13G/A 19% 2y
Adiumentum Capital Fund I LP ATRA Atara Biotherapeutics, Inc. 13D/A 19.99% 2y
JENNISON ASSOCIATES LLC PLYM Plymouth Industrial REIT, Inc. 13G/A 10.6% 2y
CANADA PENSION PLAN INVESTMENT BOARD AOMR Angel Oak Mortgage REIT, Inc. 13G/A 0% 2y
JPMORGAN CHASE & CO OM Outset Medical, Inc. 13G/A 0.2% 2y
JPMORGAN CHASE & CO LASR Nlight, Inc. 13G/A 3.4% 2y
Voss Capital, LP IMXI International Money Express, Inc. 13D 5.6% 2y
JPMORGAN CHASE & CO PEG Public Service Enterprise Group Inc 13G/A 3.7% 2y
Harraden Circle Investments, LLC SKGR SK Growth Opportunities Corporation Class A Common Stock 13G 9.94% 2y
Archon Capital Management LLC RRGB Red Robin Gourmet Burgers Inc 13G/A 4.4% 2y
Joseph Reda XXII 22nd Century Group, Inc. 13G/A 8.3% 2y